William Bonello
Stock Analyst at Craig-Hallum
(4.81)
# 475
Out of 12,268 analysts
274
Total ratings
56.7%
Success rate
23.5%
Average return
Main Sectors:
Stocks Rated by William Bonello
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCYT Veracyte | Maintained: Buy | n/a | $45.03 | - | 12 | May 22, 2026 | |
| PSNL Personalis | Maintained: Buy | n/a | $8.47 | - | 14 | May 20, 2026 | |
| MDXH MDxHealth | Maintained: Buy | $3 | $0.80 | +275.00% | 11 | May 14, 2026 | |
| WGS GeneDx Holdings | Maintained: Buy | $85 | $47.31 | +79.67% | 30 | May 13, 2026 | |
| MYGN Myriad Genetics | Rated: Buy | $10 | $3.81 | +162.47% | 9 | May 6, 2026 | |
| QDEL QuidelOrtho | Maintained: Buy | n/a | $11.86 | - | 17 | May 5, 2026 | |
| ADPT Adaptive Biotechnologies | Maintained: Buy | n/a | $13.88 | - | 10 | May 5, 2026 | |
| SRTA Strata Critical Medical | Maintained: Buy | n/a | $6.13 | - | 3 | May 5, 2026 | |
| BDSX Biodesix | Maintained: Buy | n/a | $14.93 | - | 13 | May 5, 2026 | |
| SOPH SOPHiA GENETICS | Maintained: Buy | n/a | $4.95 | - | 15 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.71 | - | 15 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.23 | - | 18 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $21.63 | - | 30 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $4.26 | +134.74% | 6 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $224 | $203.19 | +10.24% | 18 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $125 | $118.95 | +5.09% | 21 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $38.26 | - | 1 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.24 | - | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.99 | +151.26% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $276.14 | - | 2 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $33.00 | - | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.20 | n/a | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $19.08 | n/a | 1 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.10 | n/a | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $29.25 | n/a | 1 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $115.06 | n/a | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.12 | n/a | 1 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $306.88 | n/a | 1 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $71.36 | n/a | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $15.47 | n/a | 1 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $14.84 | n/a | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $11.04 | n/a | 1 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.30 | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.04 | n/a | 1 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $5.85 | n/a | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $37.03 | n/a | 1 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.78 | n/a | 2 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $15.47 | n/a | 1 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $48 | $104.96 | n/a | 1 | Feb 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $54.40 | n/a | 1 | Nov 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.602 | n/a | 2 | Oct 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $20.93 | n/a | 1 | Apr 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $24.49 | n/a | 1 | Jan 29, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $74 | $195.21 | n/a | 1 | Sep 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $116 | $259.93 | n/a | 1 | Aug 28, 2013 |
Veracyte
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $45.03
Upside: -
Personalis
May 20, 2026
Maintained: Buy
Price Target: n/a
Current: $8.47
Upside: -
MDxHealth
May 14, 2026
Maintained: Buy
Price Target: $3
Current: $0.80
Upside: +275.00%
GeneDx Holdings
May 13, 2026
Maintained: Buy
Price Target: $85
Current: $47.31
Upside: +79.67%
Myriad Genetics
May 6, 2026
Rated: Buy
Price Target: $10
Current: $3.81
Upside: +162.47%
QuidelOrtho
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $11.86
Upside: -
Adaptive Biotechnologies
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $13.88
Upside: -
Strata Critical Medical
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $6.13
Upside: -
Biodesix
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $14.93
Upside: -
SOPHiA GENETICS
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $4.95
Upside: -
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $2.71
Upside: -
Apr 29, 2026
Maintained: Buy
Price Target: n/a
Current: $9.23
Upside: -
Apr 29, 2026
Rated: Hold
Price Target: n/a
Current: $21.63
Upside: -
Mar 11, 2026
Rated: Buy
Price Target: $10
Current: $4.26
Upside: +134.74%
Mar 4, 2026
Maintained: Buy
Price Target: $224
Current: $203.19
Upside: +10.24%
Feb 20, 2026
Rated: Buy
Price Target: $125
Current: $118.95
Upside: +5.09%
Oct 29, 2025
Maintained: Buy
Price Target: n/a
Current: $38.26
Upside: -
Oct 23, 2025
Maintained: Buy
Price Target: n/a
Current: $5.24
Upside: -
Aug 18, 2025
Reiterated: Buy
Price Target: $5
Current: $1.99
Upside: +151.26%
Jun 27, 2025
Maintained: Buy
Price Target: n/a
Current: $276.14
Upside: -
Jun 25, 2025
Maintained: Buy
Price Target: n/a
Current: $33.00
Upside: -
May 5, 2025
Maintained: Buy
Price Target: n/a
Current: $13.20
Upside: n/a
Mar 10, 2025
Maintained: Buy
Price Target: n/a
Current: $19.08
Upside: n/a
Feb 21, 2025
Maintained: Buy
Price Target: n/a
Current: $7.10
Upside: n/a
Feb 19, 2025
Maintained: Buy
Price Target: n/a
Current: $29.25
Upside: n/a
Feb 12, 2025
Maintained: Buy
Price Target: n/a
Current: $115.06
Upside: n/a
Feb 10, 2025
Maintained: Buy
Price Target: n/a
Current: $25.12
Upside: n/a
Feb 6, 2025
Maintained: Buy
Price Target: n/a
Current: $306.88
Upside: n/a
Feb 4, 2025
Maintained: Hold
Price Target: n/a
Current: $71.36
Upside: n/a
Jan 31, 2025
Rated: Buy
Price Target: n/a
Current: $15.47
Upside: n/a
Jan 21, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $14.84
Upside: n/a
Jan 17, 2025
Maintained: Buy
Price Target: $21
Current: $11.04
Upside: n/a
Nov 15, 2024
Reiterated: Buy
Price Target: $4
Current: $1.30
Upside: n/a
Sep 18, 2024
Rated: Buy
Price Target: n/a
Current: $1.04
Upside: n/a
Sep 12, 2024
Rated: Buy
Price Target: $6
Current: $5.85
Upside: n/a
Aug 20, 2024
Rated: Buy
Price Target: n/a
Current: $37.03
Upside: n/a
Jul 9, 2024
Maintained: Buy
Price Target: n/a
Current: $3.78
Upside: n/a
Jun 20, 2024
Rated: Buy
Price Target: n/a
Current: $15.47
Upside: n/a
Feb 13, 2017
Initiated Coverage: Buy
Price Target: $48
Current: $104.96
Upside: n/a
Nov 9, 2016
Downgraded: Hold
Price Target: n/a
Current: $54.40
Upside: n/a
Oct 23, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.602
Upside: n/a
Apr 9, 2015
Initiated Coverage: Buy
Price Target: $7
Current: $20.93
Upside: n/a
Jan 29, 2015
Downgraded: Hold
Price Target: n/a
Current: $24.49
Upside: n/a
Sep 19, 2013
Initiated Coverage: Buy
Price Target: $74
Current: $195.21
Upside: n/a
Aug 28, 2013
Initiated Coverage: Buy
Price Target: $116
Current: $259.93
Upside: n/a